Context.-The increasing demand for immunohistochemistry for clinical diagnostics, in combination with an ongoing shortage of staff in the histology laboratory, has brought about a need for automation in immunohistochemistry. The current automated staining platforms vary significantly in their design and capabilities.
T he discovery of heat-induced epitope retrieval methods in the early 1990s launched a revolution in the practice of pathology. 1 For the first time, immunohistochemistry (IHC) could reveal a large variety of proteins in formalinfixed, paraffin-embedded tissues. As the enhanced diagnostic utility of IHC was realized, the demand for the volume and diversity of antibodies also increased, as evidenced by the proliferation of IHC publications in pathology literature. Immunostaining, however, was a manual and complex process with many steps, typically entrusted only to the most highly focused and skilled staff. To ensure quality, reproducibility, and speed with increasing volumes, there arose a need for automation. 2 Conceptually, to fully automate the IHC ''total test'' approach 3 would require machines that could reproduce all the manual steps performed in IHC, including everything from tissue-block acquisition and slide labeling to staining and quality control as well as including digital images solutions to aid in slide delivery and interpretation. Pulling the correct tissue block remains the task of a human, but technology has progressed to address most of the manual steps.
The first robotic IHC workstation, introduced in the 1980s by Brigati, 4 achieved the complex steps of reagent application and washing using a capillary action technique between paired glass slides. In the following decades, machines have been developed to manage slide labeling, baking, deparaffinization, antigen retrieval, staining, cover-slipping, and digital image analysis. [5] [6] [7] [8] Although the techniques employed by various vendors differ, automation offers sufficient advantages that there has been widespread adoption of automated IHC staining platforms.
ADVANTAGES OF AUTOMATION
There are several things to consider when adding automation to an IHC laboratory. The main advantages are found in the automation of the retrieval and staining protocols for standardization and staffing considerations. Histology laboratories nationwide have experienced an ongoing shortage of staff and increasing workloads, driving the need for automation. According to the 2012 Vacancy Survey by the Association of Clinical Pathology, 9(p13) the average staff vacancy rate in histology departments is 5.0%, and a retirement rate of 6.0% in the next 24 months is anticipated. Overall, 3.0% of positions in histology have been available for more than 6 months. The rate of histology staff vacancies left open for longer than 6 months is 4.0%.
Immunohistochemistry automation can ease the challenge of staffing shortages in several ways. Automating the immunohistochemistry section of your laboratory will free up technologist time to perform cutting and embedding, which lack reasonable options for automation. In larger laboratories, histotechnologists on multiple shifts, each with individual tendencies and variable interruptions, could benefit from the standardization provided by automation. Performing the prepared protocols on the automated instruments is less demanding, and that work can be shared by more staff members. Instruments offer process monitoring for errors with alarms for events such as inappropriate temperatures, inadequate reagent volumes, or even incorrectly selected reagents identified through barcode tracking. The systems may also employ computerized software capable of tracking reagent stock and expiration dates, aiding in reagent inventory management. Each of those benefits decreases the demands placed on staff. the era of manual staining spent endless hours of trial and error attempting to optimize manual protocols, becoming highly knowledgeable about the IHC staining processes. Automation separates staff from the staining process through mechanization, which increases the likelihood that the person running the IHC instrumentation might have insufficient knowledge for troubleshooting the staining process when a stain is suboptimal. Any laboratory performing IHC needs some personnel who oversee the IHC section to have specialized knowledge that adequately ensures the proper functioning of the assays.
DISADVANTAGES OF AUTOMATION
Of course, as we become dependent on automation, we must keep in mind that any machine periodically requires maintenance or repair. More-complex systems are not necessarily better systems. The greater the number of moving parts an instrument has, the more opportunities there are for parts to malfunction. Sufficient redundancy should be in place to accommodate instrument downtime, scheduled or otherwise.
The greatest advantage left to manual staining is the almost infinite flexibility in choosing reagents and retrieval methods and in the ability to attempt subtle variations in technique when optimizing a staining protocol. The standardization of automation is achieved by ''closing'' the instrument to opportunities for variations introduced by human participation.
OPEN AND CLOSED SYSTEMS
Automated platforms vary in their flexibility for variables permitted at each of the staining protocol steps. This has resulted in automated systems being designed and described as open or closed depending on how similar the flexibility is to manual staining in the diverse reagent choices and timing of staining steps. 10 For this reason, open automated systems are the easiest to migrate to from manual protocols with the least need for alterations. Open automated systems are often preferred in research settings, where the main concern may be developing new staining protocols for the growing number of target biomarkers, requiring flexibility in protocol options.
In contrast, in the clinical setting, where priority is given to reproducing established protocols, in greater volumes, performed by more testing personnel, assays can benefit from the reproducibility of closed standardized processes. Automated systems are described as increasingly closed the more they limit protocols to the use of proprietary antibodies, reagents, and detection systems and restrict the options available in the software to vary the steps of the protocol.
HEAT
The term closed is also used to refer to systems that perform onboard heating under the ''closed'' lids of the system. Heat can be used for several purposes in the staining process. Slide baking secures a tissue section to the slide and is an option on some current automated staining platforms, but many laboratories choose to do this step in a separate oven, which frees up time for the other steps of staining to increase the throughput on the equipment.
The most important function of heating is for heatinduced epitope retrieval. A great emphasis is placed on this because heat-induced epitope retrieval is necessary in most staining protocols. Some vendors have adopted the strategy of creating pretreatment modules for heating, separate from their staining instruments. This offers the advantage of automation for pretreatment in a single module, which may supply retrieved slides for multiple staining instruments in the laboratory.
An advantage for systems that incorporate the slide heating function into the staining instrumentation is the ability to apply heat during incubation of reagents to accelerate reaction times.
Heat is also a necessary step in denaturing doublestranded DNA targets for DNA in situ hybridization procedures, such as those to detect human papillomavirus. Heat is not required, however, for in situ hybridization to detect single-stranded RNA molecules, such as in the case of Epstein-Barr virus. RNA in situ hybridization can be performed on nonheated platforms as long as there is a detection system for in situ hybridization available for the instrument.
SLIDE MANAGEMENT
Instrument vendors differ greatly regarding how slides are loaded, covered, and batched through the staining process to address overall capacity and speed. Early robotic platforms held paired slides in a vertical orientation to take advantage of gravity to apply and rinse reagents from the slide surface with capillary action. This has been replaced in current systems with slides loaded in trays or racks in a horizontal orientation with reagents applied from above and spread around the slide surface by either air or capillary action. The slides are protected from evaporation and drying with various techniques, including covering slides with other slides, cover tiles, or liquid coverslips.
In general, there has been a move from the large batches of slides in the past toward smaller batches and even singleslide processing. Some vendors consider small trays of 5 to 10 slides to be optimal because multiple stains from the same case can be grouped and are typically released to the pathologist at the same time. Consider that there can be great variation in the time required for different slides in a batch to complete their staining cycle. In fact, different staining protocols may vary from minutes for some direct immunofluorescence assays to several hours for multiplexed stains or in situ hybridization. If a staining system requires all the stains in a batch for the slide with the longest protocol to finish, many slides and staining slots are not being used to the greatest advantage. This variation in protocol lengths argues for single-slide processing rather than batches. With independent slots for individual slide processing, each of the slots in a platform achieves the fastest throughput. In a recent white paper 11 describing comparisons of batch versus single-slide IHC workflow optimization at the Cleveland Clinic Foundation, many advantages were described for the single-slide workflow. The study showed that adopting single-slide workflow resulted in reduced overall IHC turnaround times, the addition of a fourth-order cutoff time, increased slide throughput per laboratory professional, and improved ability to integrate urgent or STAT slides easily into routine workflow.
REAGENT MANAGEMENT
The number of reagent containers that can be loaded onto automated staining platform from different vendors varies greatly. In general, more slots available for reagent containers enable more antibodies and detections to be run without swapping out containers. Some systems offer cooling of reagents, which may be particularly valuable for labile reagents such as alkaline phosphatase.
All automated IHC systems require a mechanism to delivery precise amounts of reagents to the slides. Matrix and rotary are terms used to describe the motion of the robotic mechanisms that bring the reagents to the microscopic slides in automated IHC systems. 12 Most automated systems use the array or matrix architecture. In array systems, the slides and reagents are each arranged in rows and columns and robotic arms move back and forth across the array dispensing reagents onto slides and returning to reagent vials to rinse and refill with the next reagent to dispense. Systems with more than one robotic arm have the ability to delivery more reagents simultaneously to speed up the staining process.
In the rotary systems, the slides and reagents are placed around 2 separate, rotating, circular platters. The reagent platter is located above the slide platter. Rotation of the platters brings reagent containers into position above slides to directly dispense their fluids onto the slides. In this way, each reagent container acts as its own dispenser eliminating the possibility for cross-contamination. There is no need to rinse aspiration probes or exchange disposable pipette tips between uses on different reagents, as done with array/ matrix systems. The rotary reagent dispensers deliver a standard amount of reagent with each compression of the plunger. Some pipetting systems of the array platforms offer more control of smaller amounts of reagent to each slide. Most automated stainers, however, require a specific amount of fluid be dispensed at each step of a protocol for the capillary action or air pressure to distribute the reagent across the entire slide. Because of that, the reagent concentration must be varied to deliver the correct amount of reagent within that required dispensing volume.
''Ready-to-Use'' Reagents Vendors vary in how open their system is to accepting antibodies and detection systems from other vendors. Most instrument vendors provide options for using their own prediluted antibodies but also allow customer-prepared antibodies to be loaded into empty reagent containers. Prediluted or ''ready-to-use'' antibodies provide significant convenience over reagents that must be prepared from concentrates. The labor savings of prediluted antibodies is, however, reflected in increased product costs. The use of prediluted antibodies also limits the flexibility of staining protocol optimization by removing the ability to adjust the antibody concentration. When using prediluted antibodies, optimization is mainly achieved by adjustments to the retrieval method and primary antibody incubation times, because the antibody dilution cannot be altered. Detection reagents are typically proprietary and sold in formats compatible with the automated equipment.
WASTE MANAGEMENT
Diaminobenzidine is the most common chromogen used in IHC assays. Unfortunately, diaminobenzidine is hazardous, and has a special, more-expensive handling requirement as a waste product. If kept separate from nonhazardous waste, the expense of handing or neutralizing the diaminobenzidine is reduced; if, however, the diaminobenzidine is combined with nonhazardous waste, all the waste must be processed as hazardous waste. Several vendors use strategies that limit the initial volumes of reagents required. Examples include employing small, walled-off reaction chambers on the slides or permitting control of the amount of reagent that is dispensed. One vendor employs a unique waste strategy that produces no liquid waste because all waste is collected in an absorbent material within the waste cartridge and disposed of as solid waste. Waste disposal costs are just one of the ongoing operating costs that should be taken into account, in addition to the initial purchase price of a system. Other costs may come in the form of consumables (proprietary reagents, containers, pipette tips), service contracts, and even interfacing costs to connect to laboratory information systems.
COMPARING SYSTEM FEATURES When evaluating automated staining systems, the first thing to understand is that there is no, one ''best system'' on the market, for all purposes. 12 In fact, the existence of so many diverse staining technologies argues that each has an audience with diverse needs and wants. The best approach when considering adopting an automated staining system is to start with an understanding of the proposed use. 10, 13 There are many factors to consider when deciding on the appropriate automated staining platform. There must be adequate space available for the equipment and associated reagents. The capacity, speed, and flexibility of the batches for continuous processing should match the needs for volume and turnaround time. The platform should provide flexibility and openness for reagent choices and protocol options to meet the number and difficulty of optimizations you will be performing. The value of automated heating to perform onboard retrieval protocols and DNA target denaturation should fit with planned testing. Systems vary in their ability to produce multiplexed, dual-color staining. There may be value from reagent chilling capabilities, depending on the stability of chromogen substrates you will be using. The software-user interface should be easily understood by your staff and provide useful functionality, including operator alerts of suboptimal heating or insufficient or incorrect reagents, workload reports, stain use, lot-to-lot validations, and reagent inventory management. Higher-volume IHC laboratories can benefit from the additional automation acquired through order interfacing and barcode tracking with the staining platform, and, of course, the time and cost saving of the automation through better use of limited staff for other manual tasks should be worth the overall purchase price and the operating costs of the testing system. An overview of the comparative features of current automated IHC platforms is presented in the Table. If you understand the needs of your laboratory and the capabilities of the various systems, you can find the best fit for your laboratory. If an automated IHC platform is chosen correctly to match the demands of testing, automation can provide necessary process improvement and cost savings needed in the modern practice of pathology.
